Trident Lifeline rises on acquiring additional stake in Trident Mediquip
Trident Lifeline is currently trading at Rs. 322.00, up by 3.00 points or 0.94% from its previous closing of Rs. 319.00 on the BSE.
The scrip opened at Rs. 327.00 and has touched a high and low of Rs. 327.00 and Rs. 317.00 respectively. So far 17400 shares were traded on the counter.
The BSE group 'M' stock of face value Rs. 10 has touched a 52 week high of Rs. 327.00 on 02-Jan-2025 and a 52 week low of Rs. 222.00 on 04-Mar-2025.
Last one week high and low of the scrip stood at Rs. 327.00 and Rs. 265.00 respectively. The current market cap of the company is Rs. 384.24 crore.
The promoters holding in the company stood at 63.11%, while Institutions and Non-Institutions held 8.12% and 28.78% respectively.
Trident Lifeline has made further Investment by acquiring an additional equity stake of 9.04% of Trident Mediquip (TML), a subsidiary company from existing shareholders of the Company. Pursuant to the above, the shareholding of the company in TML has increased from 51% to 60.04%. Cost of acquisition is around Rs 4.42 crore.
Trident Lifeline is engaged in the pharmaceutical business ethical marketing in domestic as well as international market.
